Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1619
This examiner grants 44% of resolved cases
NGUYEN, JOHN P operates within Tech Center 1600 and Art Unit 1619, where they have managed 408 resolved cases. This volume of cases indicates the examiner's level of experience in handling patent applications within this technology sector. The examiner maintains an allowance rate of 43.9 percent, which provides a baseline for the probability of securing a patent grant. This percentage suggests the likelihood that an application reaching a final disposition will be allowed. Practitioners can use this figure to gauge the general receptivity of the examiner to patentable subject matter.
The data shows an interview lift of 41.8 percent, indicating how direct communication correlates with the probability of success. The interview lift of 41.8 percent is lower than the 43.9 percent allowance rate, which helps determine the relative impact of verbal engagement. The median days to allowance stands at 1180, providing a timeline expectation for the prosecution process from filing to grant. This duration reflects the typical pendency for successful applications. Understanding these metrics allows for a more informed strategy when navigating the examination process with this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17636209 | Metabolic Reprogramming of Immune Cells for the Treatment or Prevention of Diseases and Disorders | Non-Final OA | Arizona Board of Regents on behalf of Arizona State University |
| 17054441 | SELF-MANAGEABLE ABNORMAL SCAR TREATMENT WITH SPHERICAL NUCLEIC ACID (SNA) TECHNOLOGY | Non-Final OA | NORTHWESTERN UNIVERSITY |
| 17235771 | BIOLOGICALLY ACTIVE DRY POWDER COMPOSITIONS AND METHOD OF THEIR MANUFACTURE AND USE | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18658140 | ROACH GEL FORMULATIONS | Non-Final OA | S. C. JOHNSON & SON, INC. |
| 18073852 | DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS | Non-Final OA | YALE UNIVERSITY |
| 17227381 | HYDROGEL COMPOSITION AND HYDROGEL LENS | Final Rejection | PEGAVISION CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy